Development and validation of a nomogram risk prediction model for PICC-related thrombosis in children with

Maoling Fu1,2, Qiaoyue Yang1,2, Xiao Wu1

  • 1Department of Nursing, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

A new tool can predict peripherally inserted central catheter (PICC)-related thrombosis in children with blood cancers. This aids early identification of high-risk patients, improving outcomes and preventing complications.

Area of Science:

  • Pediatric Hematology
  • Vascular Access Devices
  • Thrombosis Research

Background:

  • Peripherally inserted central catheter (PICC)-related thrombosis is a significant complication in pediatric hematological malignancies.
  • Early identification of at-risk patients is critical for effective prevention strategies.

Purpose of the Study:

  • To develop and validate a clinical risk prediction tool for PICC-related thrombosis in pediatric patients with hematological malignancies.
  • To identify independent risk factors associated with PICC-related thrombosis in this population.

Main Methods:

  • Retrospective analysis of 519 children with hematological malignancies undergoing PICC catheterization.
  • Analysis of 54 potential predictor variables to identify independent risk factors.
  • Development and validation of a prediction model using training and validation sets, assessed by AUC, calibration, and decision curve analysis.

Main Results:

  • PICC-related thrombosis occurred in 98 (18.9%) of the studied children.
  • Six independent risk factors were identified: leukemia, number of catheters, catheterization history, total parenteral nutrition, post-catheterization D-dimer, and post-catheterization fibrinogen.
  • The prediction model demonstrated good performance with AUCs of 0.844 (training) and 0.794 (validation).

Conclusions:

  • A validated clinical prediction tool, visualized via nomogram, can effectively support the early prediction of PICC-related thrombosis in pediatric hematological malignancy patients.
  • The model shows significant clinical utility for identifying high-risk individuals, enabling timely intervention and potentially reducing complication rates.